Clinical trials
Phase 1/2 Multiple Myeloma trials in Greece
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 6 |
| Recruiting | 5 |
| Terminated | 4 |
| Completed | 3 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 4 |
| Celgene | 3 |
| Hellenic Society of Hematology | 3 |
| Regeneron Pharmaceuticals | 2 |
| Amgen | 1 |
| Bayer | 1 |
| BeOne Medicines | 1 |
| Bristol-Myers Squibb | 1 |
| Genmab | 1 |
| Pharmacyclics LLC. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 20 |
| Recurrence | 4 |
| Blood Protein Disorders | 2 |
| Corneal Diseases | 2 |
| Hematologic Diseases | 2 |
| Neoplasms | 2 |
| Neoplasms, Plasma Cell | 2 |
| Paraproteinemias | 2 |
| Hodgkin Disease | 1 |
| Leukemia, Myeloid, Acute | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.